Capital Group Investment Management’s Boston Scientific BSX Stock Holding History

Capital Group Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	26,800 -6,417	-19%	-$348K	0.17%	104
2026 Q1	$2.08M	Sell	33,217 -18,641	-36%	-$1.49M	0.36%	78
2025 Q4	$4.94M	Buy	51,858 +8,396	+19%	+$823K	0.8%	37
2025 Q3	$4.24M	Sell	43,462 -4,032	-8%	-$418K	0.71%	43
2025 Q2	$5.1M	Hold	47,494	–	–	0.91%	29
2025 Q1	$4.79M	Buy	47,494 +4,535	+11%	+$457K	0.98%	29
2024 Q4	$3.84M	Buy	42,959 +20,523	+91%	+$1.81M	0.73%	40
2024 Q3	$1.88M	Buy	22,436 +8,256	+58%	+$651K	0.38%	77
2024 Q2	$1.09M	Buy	14,180 +1,480	+12%	+$108K	0.24%	96
2024 Q1	$870K	Buy	+12,700	New	+$817K	0.16%	143

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Capital Group Investment Management's BSX Position: Q2 2026 in Review

Capital Group Investment Management reduced its Boston Scientific (BSX) stake by 19% in Q2 2026, selling an estimated $348K and leaving 26,800 shares worth $1.14M. The position accounts for 0.17% of the portfolio, ranked #104.

Capital Group Investment Management first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.1M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Capital Group Investment Management held 26,800 shares of Boston Scientific worth $1.14M as of Q2 2026.
Capital Group Investment Management sold 6,417 Boston Scientific shares in Q2 2026, an estimated $348K.
Boston Scientific made up 0.17% of Capital Group Investment Management's portfolio in Q2 2026, its #104 holding.
Capital Group Investment Management first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
Capital Group Investment Management's Boston Scientific position peaked at $5.1M in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital Group Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.